Status:
COMPLETED
Amevive Wisdom Acquired From Real-Time Evidence (A.W.A.R.E™) Program
Lead Sponsor:
Astellas Pharma Inc
Conditions:
Plaque Psoriasis
Eligibility:
All Genders
16+ years
Brief Summary
Purpose: To develop a real time national clinical database to support and share best practices, 1. To generate hypotheses for future clinical research 2. To understand how AMEVIVE is used in routine...
Eligibility Criteria
Inclusion
- Amevive is clinically indicated for the patient
Exclusion
- Amevive is contraindicated for the patient
Key Trial Info
Start Date :
June 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2008
Estimated Enrollment :
426 Patients enrolled
Trial Details
Trial ID
NCT00371774
Start Date
June 1 2005
End Date
May 1 2008
Last Update
November 17 2011
Active Locations (30)
Enter a location and click search to find clinical trials sorted by distance.
1
Calgary, Alberta, Canada, T2S 3B3
2
Calgary, Alberta, Canada, T3A 2N1
3
Edmonton, Alberta, Canada, T5J 3S9
4
Edmonton, Alberta, Canada, T5K 1X3